Premia Spine CEO Ron Sacher confirms reports that the company has raised $7 million in a $10 million funding round in support of wider clinical trials for the company’s spinal plates. Israeli device maker Premia Spine confirmed today that it had raised $7 million, planning on using part of the funds to pursue FDA approval for its spinal fixation devices. CEO Ron Sacher told MassDevice.com today that the reports about the company’s latest fundraising efforts are true, and that Premia is looking to raise another $3 million to close out the financing round.
Help employers find you! Check out all the jobs and post your resume.
